We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksTILS.L Share News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Iconic Labs CEO; Tiziana Hires Executive Director

Fri, 05th Feb 2021 12:28

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Friday and not separately reported by Alliance News:

----------

Iconic Labs PLC - London-based media company - Appoints Sarah Dees as chief executive with immediate effect. Dees has a "wealth of management and fundraising experience" across a variety of sectors including financial technology, banking, live events and natural resources. "I am delighted to have the opportunity to lead Iconic Labs through the next phase of its development following the recent board changes. I will be prioritising early dialogue with OTT Holdings, alongside existing shareholders and lenders," Dees says.

On Monday, Iconic Labs received termination notices for management service agreements with Greencastle Capital for TheLondonEconomic, with management service agreement for JOE Media and Lovin' Media also terminated. Iconic Labs noted that the agreements represented the most significant proportion of Iconic's revenue to date. The termination notices cited the resignation of Iconic's senior management team, with John Quinlan, Liam Harrington and Sam Asante all resigning due to the failure of European High Growth Opportunities Securitization Fund to accept a revised settlement offer as well as outstanding issues with OTT Holdings Ltd and Alpha Blue Ocean.

----------

Tiziana Life Sciences PLC - London-based therapeutics for oncology, inflammation and infectious diseases - Appoints Thomas Adams as an executive director. Adams will assume the position of head of Drug Development with immediate effect, and his executive role will be to manage and oversee the company's pre-clinical and clinical drug development programmes and associated intellectual property. He is currently a director at Hepion Pharmaceuticals Inc.

----------

All Active Asset Capital Ltd - London-based firm seeking investment opportunities in the technology, software and artificial intelligence space - Intends to appoint Colin McQuade as a non-executive director. He is currently chief technology officer for BGL Group Ltd, a financial services business specialising in home and vehicle insurance, and prior to this was head of Change Technology at Barclays International.

----------

CPPGroup PLC - Leeds-based insurance and financial services company - Says Nick Cooper will be stepping down from the board and his position as a non-executive director at the end of the month to focus on his executive role as general counsel & company secretary of Johnson Matthey PLC.

----------

Prairie Mining Ltd - Poland-focused coal development firm - Notified that Todd Hannigan will resign as an alternate director to Tom Todd on Friday as he concentrates on other business and investment opportunities. Tom Todd will continue to serve as a non-executive director.

----------

Record PLC - specialist currency manager - Says Bob Noyen, chief investment officer of Record Currency Management Ltd, has decided to step down from the board of Record to focus more on his day-to-day role, though his responsibilities remain unchanged and he will continue to serve on the board of Record Currency Management.

----------

Sensyne Health PLC - Oxford, England-based clinical technology company - Appoints Hina Zaman as managing director of Healthcare Division and Martin Gouldstone as chief business officer of Life Sciences Division. Zaman joins Sensyne from Babylon Health, while Gouldstone joins from Syneos where he was global SVP Capital Solutions at Syneos One.

----------

Wishbone Gold PLC - precious metals trading and exploration company with assets in Australia - Hires David Hutchins as non-executive director effective Friday. He is currently chair of the FTSE Gold Mines Index Committee.

----------

Intertek Group PLC - London-based quality assurance provider - Hires Lynda Clarizio as a non-executive direct effective March 1. She served as president of US Media at Nielsen Holdings PLC and is currently a director of CDW Corp, Emerald Holding Inc, Adjust GmbH, OpenSlate and Resonate Networks Inc. Louise Makin will be stepping down from the board as a non-executive director on June 30 after serving for nine years.

----------

Digitalbox PLC - Bath, England-based digital media business that owns The Daily Mash and The Tab - Says Non-Executive Nigel Burton has resigned with immediate effect in order to pursue other opportunities.

----------

Gulf Marine Services PLC - Abu Dhabi-founded provider of self-propelled self-elevating support vessels for oil, gas and renewable energy industries - Says Hassan Heikal has agreed to take up the role of deputy chair, having joined the board in November 2020 as a non-executive director. Jyrki Koskelo is joining the group as an independent non-executive director, with immediate effect, bringing "extensive additional business advisory experience" to the board. Koskelo is currently a board member, and chair of the investment committee, of the Africa Agriculture & Trade Investment Fund

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
7 Feb 2019 11:40

Tiziana Life Sciences Non-Exec Director Riccardo Dalla-Favera Resigns

LONDON (Alliance News) - Tiziana Life Sciences PLC on Thursday said Non-Executive Director Riccardo Dalla-Favera has resigned from his role."The company is grateful to Favera for his

Read more
3 Dec 2018 14:27

Tiziana completes patient enrolment in ongoing Milciclib study

(Sharecast News) - Biotechnology company Tiziana Life Sciences announced on Monday that patient enrolment in its ongoing Phase 2a clinical trial, known as CDKO-125A-010, was now completed.

Read more
3 Dec 2018 11:51

Tiziana Life Completes Patient Enrollment In Liver Cancer Trial

LONDON (Alliance News) - Tiziana Life Sciences PLC on Monday said it completed patient enrollment in a Phase 2a trial of Milciclib in hepatocellular carcinoma.The company explained that the

Read more
28 Nov 2018 12:19

Tiziana Life Sciences Begins First-In-Human Phase 1 Trial Of Foralumab

LONDON (Alliance News) - Tiziana Life Sciences PLC on Wednesday said it began the first in-human trial of Foralumab, a treatment for autoimmune diseases.The biotechnology company said the a

Read more
20 Nov 2018 12:53

Tiziana Life Sciences Prices ADS Offering, Raises GBP3.4 Million

LONDON (Alliance News) - Tiziana Life Sciences PLC said Tuesday that it has priced its underwritten public offering in the US of 442,910 American Depositary Shares representing ordinary shares in

Read more
25 Sep 2018 13:43

Tiziana Life Seeks Listing Of ADS On Nasdaq Capital Market (ALLIPO)

LONDON (Alliance News) - Tiziana Life Sciences PLC said Tuesday that it has commenced underwritten public offering in the US of American Depositary Shares representing ordinary shares in the UK of

Read more
24 Sep 2018 12:37

Tiziana Half-Year Loss Unchanged; Gets US Approval For Foralumab Trial

LONDON (Alliance News) - Tiziana Life Sciences PLC on Monday reported a flat loss in the first half of 2018 as expenses were broadly unchanged, while the biotechnology firm also announced that its

Read more
17 Aug 2018 11:39

DIRECTOR DEALINGS: Tiziana Life Chairman Associate Buys Shares

LONDON (Alliance News) - Tiziana Life Sciences PLC said Friday that Panetta Partners Ltd, a company associated with Chairman Gabriele Cerrone, bought shares in the company worth acquired 469,766 a

Read more
16 Aug 2018 11:47

Tiziana seeks trial for multiple sclerosis 'game changer'

(Sharecast News) - Tiziana Life Sciences on Thursday submitted an application to initiate phase one clinical trials for a new treatment of neurodegenerative diseases to the US food and drug administration.

Read more
27 Jul 2018 11:14

Tiziana Life Sciences Files For IPO Of American Depositary Shares (ALLIPO)

LONDON (Alliance News) - Tiziana Life Sciences PLC said Friday it filed a registration statement with the US Securities Exchange Commission for a proposed initial public offering of its American

Read more
16 May 2018 13:27

Tiziana Life Science Reports Progress In Milcicib Phase 2a Trial

LONDON (Alliance News) - Biotechnology company Tiziana Life Sciences PLC said Wednesday that the phase 2a trial of Milciclib safety and tolerability in patients with Metastatic Hepatocellular has

Read more
19 Apr 2018 14:44

Tiziana Raises GBP825,000 Through Placing Of 1 Million Shares (ALLISS)

LONDON (Alliance News) - Tiziana Life Sciences PLC said Thursday it has raised GBP825,000 from the issue of 1.0 million new shares at a price of 80 pence per share.The cancer and autoimmune

Read more
4 Apr 2018 12:53

Tiziana Appoints Leopoldo Zambeletti As Non-Executive Director

LONDON (Alliance News) - Tiziana Life Sciences PLC, a biotechnology company developing drugs for cancer and autoimmune diseases, said Wednesday Leopoldo Zambeletti has joined

Read more
16 Nov 2016 09:34

Tiziana Life Sciences makes breakthrough oral treatment for inflammatory diseases

(ShareCast News) - Tiziana Life Sciences, the clinical stage biotechnology company, announced that new data has demonstrated the potential of its novel oral therapy with foralumab for non-alcoholic steatohepatitis (NASH), diabetes and other life threatening inflammatory diseases. Oral efficacy in hu

Read more
18 Jul 2016 12:03

Tiziana Life looks for secrets of long life with new acquisition

(ShareCast News) - Tiziana Life Sciences has purchased key assets from Sardinia-based biobanking and genomics research company Shardna for €258,000, giving it access to the genetic data of nearly 13,000 people from the Ogliastra region, where life expectancy is high. The AIM-listed clinical stage bi

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.